These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 8329787)
1. Unmasking the significant enzyme-inducing effects of phenytoin on serum carbamazepine concentrations during phenytoin withdrawal. Chapron DJ; LaPierre BA; Abou-Elkair M Ann Pharmacother; 1993 Jun; 27(6):708-11. PubMed ID: 8329787 [TBL] [Abstract][Full Text] [Related]
2. Differential effect of cimetidine on serum concentrations of carbamazepine and phenytoin. Levine M; Jones MW; Sheppard I Neurology; 1985 Apr; 35(4):562-5. PubMed ID: 3982643 [TBL] [Abstract][Full Text] [Related]
3. Reversal by phenytoin of carbamazepine-induced water intoxication: a pharmacokinetic interaction. Perucca E; Richens A J Neurol Neurosurg Psychiatry; 1980 Jun; 43(6):540-5. PubMed ID: 7205298 [TBL] [Abstract][Full Text] [Related]
4. Lacosamide serum concentrations in adult patients with epilepsy: the influence of gender, age, dose, and concomitant antiepileptic drugs. Markoula S; Teotonio R; Ratnaraj N; Duncan JS; Sander JW; Patsalos PN Ther Drug Monit; 2014 Aug; 36(4):494-8. PubMed ID: 24562047 [TBL] [Abstract][Full Text] [Related]
5. Therapeutic plasma levels of phenytoin, phenobarbital, and carbamazepine: individual variation in relation to seizure frequency and type. Schmidt D; Haenel F Neurology; 1984 Sep; 34(9):1252-5. PubMed ID: 6540414 [TBL] [Abstract][Full Text] [Related]
6. Chronotherapeutic dose schedule of phenytoin and carbamazepine in epileptic patients. Yegnanarayan R; Mahesh SD; Sangle S Chronobiol Int; 2006; 23(5):1035-46. PubMed ID: 17050216 [TBL] [Abstract][Full Text] [Related]
8. Hazards of doubling phenytoin dose in the face of an unrecognized interaction with ciprofloxacin. Pollak PT; Slayter KL Ann Pharmacother; 1997 Jan; 31(1):61-4. PubMed ID: 8997469 [TBL] [Abstract][Full Text] [Related]
10. [Loading-doses of carbamazepine and diphenylhydantoin: use in high-risk patients]. Leite PJ; Tsanaclis LM; Markourakis T; Bittencourt PR Arq Neuropsiquiatr; 1987 Sep; 45(3):281-7. PubMed ID: 3439906 [TBL] [Abstract][Full Text] [Related]
11. Carbamazepine-phenytoin interaction: elevation of plasma phenytoin concentrations due to carbamazepine comedication. Zielinski JJ; Haidukewych D; Leheta BJ Ther Drug Monit; 1985; 7(1):51-3. PubMed ID: 3992622 [TBL] [Abstract][Full Text] [Related]
12. [Decrease of folic acid and cognitive alterations in patients with epilepsy treated with phenytoin or carbamazepine, pilot study]. Hernández R; Fernández Mde L; Miranda G; Suástegui R Rev Invest Clin; 2005; 57(4):522-31. PubMed ID: 16315636 [TBL] [Abstract][Full Text] [Related]
13. The effect of combination therapy on the plasma concentrations of traditional antiepileptics: a retrospective study. Sirmagul B; Atli O; Ilgin S Hum Exp Toxicol; 2012 Oct; 31(10):971-80. PubMed ID: 22588177 [TBL] [Abstract][Full Text] [Related]
14. Phenytoin and carbamazepine, alone and in combination: anticonvulsant and neurotoxic effects. Morris JC; Dodson WE; Hatlelid JM; Ferrendelli JA Neurology; 1987 Jul; 37(7):1111-8. PubMed ID: 3601077 [TBL] [Abstract][Full Text] [Related]
16. Measurement of phenytoin and carbamazepine in an ultrafiltrate of saliva. Schramm W; Annesley TM; Siegel GJ; Sackellares JC; Smith RH Ther Drug Monit; 1991 Sep; 13(5):452-60. PubMed ID: 1957339 [TBL] [Abstract][Full Text] [Related]
17. [Serum lipids. lipoproteins, and apolipoproteins in adult epileptics treated with carbamazepine, valproic acid, or phenytoin]. Pita-Calandre E; Rodríguez-López CM; Cano MD; Peña-Bernal M Rev Neurol; 1998 Nov; 27(159):785-9. PubMed ID: 9859151 [TBL] [Abstract][Full Text] [Related]
18. Carbamazepine and phenytoin. Comparison of cognitive effects in epileptic patients during monotherapy and withdrawal. Gallassi R; Morreale A; Lorusso S; Procaccianti G; Lugaresi E; Baruzzi A Arch Neurol; 1988 Aug; 45(8):892-4. PubMed ID: 3395263 [TBL] [Abstract][Full Text] [Related]
19. Carbamazepine drug interactions: the influence of concurrent drug therapy on serum concentrations of carbamazepine and its epoxide metabolite. Wang RB; Liu LT; Yiu CH; Chang TY Zhonghua Yi Xue Za Zhi (Taipei); 1990 Apr; 45(4):222-32. PubMed ID: 2168269 [TBL] [Abstract][Full Text] [Related]
20. Dosage adjustments in response to monitored plasma concentrations: can unblinded staff adhere to objective criteria? Sahlroot JT; Pledger GW J Biopharm Stat; 1994 Mar; 4(1):91-100. PubMed ID: 8019586 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]